Top Markets
#1 Siren Siren +30.60%
#2 OriginTrail OriginTrail +26.61%
#3 Waves Waves +12.47%
#4 Tutorial Tutorial +10.44%
#5 MarsCoin MarsCoin +9.18%
#6 Pons Pons +8.78%
#7 Concordium Concordium +6.10%
#8 PulseChain PulseChain +5.89%
#9 Fabric Protocol Fabric Protocol +5.35%
#10 COTI COTI +5.13%
Coin of the day
Siren Siren
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
3D Global Biotech Inc. 3D Global Biotech Inc.

3D Global Biotech Inc.

6808
Classifica tra le azioni #22396
Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in... Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.
Prezzo delle azioni
$1.16
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$89.35M
Variazione (1 giorno)
-1.22%
Variazione (1 anno)
-15.74%
Paese
TW
Scambia 3D Global Biotech Inc. (6808)

Categoria

Healthcare
Ricavi di 3D Global Biotech Inc. (6808)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di 3D Global Biotech Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per 3D Global Biotech Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH